The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The degree of reactogenicity after one dose of mRNA-1273 was less than that observed for the recombinant adjuvanted zoster vaccine, and after the second mRNA-1273 dose it was similar to that of the zoster vaccine.
“The degree of reactogenicity after one dose of mRNA-1273 was less than that observed for the recently approved recombinant adjuvanted zoster vaccine and after the second mRNA-1273 dose was similar to that of the zoster vaccine. 21,22”
From Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine (2021) · cites this paper as [22]
Citations
Cites
Leroux-Roels, I., Leroux-Roels, G., Clement, F., Vandepapelière, P., Vassilev, V., Ledent, E., & Heineman, T. C. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis497 · Cited by 147
Self-citation
Flagged first, then by citations
Research works printed but not linked: 8
- 10.1056/NEJMoa1501184 · DOI · Paper page
- 10.1002/(SICI)1096-9071(199812)56:4<337::AID-JMV9>3.0.CO;2-3 · DOI
- Bernstein HH, 1993, Pediatrics, 92, 833, 10.1542/peds.92.6.833 · DOI
- 10.1016/j.vaccine.2014.01.019 · DOI
- 10.1093/infdis/jis497 · DOI · Paper page
- 10.1093/infdis/jit365 · DOI · Paper page
- 10.1016/j.vaccine.2014.01.019 · DOI
- 10.1056/NEJMoa1501184 · DOI · Paper page
Cited by
Sorted by citations
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
Baden, L. R., El Sahly, H. M., Essink, B., Kotloff, K., Frey, S., Novak, R., Diemert, D., Spector, S. A., Rouphael, N., Creech, C. B., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2035389 · Cited by 10,119
Metadata
- Authors
- Lal, H., Cunningham, A. L., & Heineman, T. C.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2015-10-15
- Volume
- 373
- Issue
- 16
- Pages
- 1575-1577
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2190816033
- Cited by
- 33
- References
- 1
- Citations by year
- 2026: 1 · 2025: 2 · 2023: 1 · 2022: 4 · 2021: 5 · 2020: 4 · 2019: 4 · 2018: 6 · 2017: 2 · 2016: 3 · 2015: 1
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Herpesvirus Infections and Treatments
- Health Sciences › Medicine › Epidemiology › Cytomegalovirus and herpesvirus research
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Keywords
- herpes zoster, subunit vaccine, adjuvants, older adults, vaccine efficacy, herpes zoster prevention
- MeSH terms
- Female, Herpes Zoster, Humans, Male, Herpes Zoster Vaccine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
